The IL-15-based ALT-803 complex enhances FcγRIIIa-triggered NK cell responses and in vivo clearance of B cell lymphomas

PURPOSE: Anti-CD20 monoclonal antibodies (mAbs) are an important immunotherapy for B cell lymphoma, and provide evidence that the immune system may be harnessed as an effective lymphoma treatment approach. ALT-803 is a super-agonist IL-15 mutant and IL-15Rα–Fc fusion complex that activates the IL-15...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Rosario, Maximillian, Bai, Liu, Kong, Lin, Collins, Lynne I., Schneider, Stephanie E., Chen, Xiaoyue, Han, Kaiping, Jeng, Emily K., Rhode, Peter R., Leong, Jeffrey W., Schappe, Timothy, Jewell, Brea A., Keppel, Catherine R., Shah, Keval, Hess, Brian, Romee, Rizwan, Piwnica-Worms, David R., Cashen, Amanda F., Bartlett, Nancy L., Wong, Hing C., Fehniger, Todd A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4738096/
https://ncbi.nlm.nih.gov/pubmed/26423796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-1419
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados